Shareholding19 May 2026, 05:21 pm
Interface Fin Services Sells 4.47% Stake in Biogen Pharmachem
AI Summary
Interface Financial Services Ltd. disclosed the sale of 4,03,03,000 shares in Biogen Pharmachem Industries Limited, representing 4.47% of the total share capital. This transaction occurred under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Following the sale, Interface Financial Services Ltd.'s holding in Biogen Pharmachem stands at 4,36,97,000 shares, or 4.84% of the total share capital. The equity share capital of Biogen Pharmachem remains at ₹90,26,03,000.
Key Highlights
- Interface Financial Services sold 4.47% stake in Biogen Pharmachem.
- The sale involved 4,03,03,000 shares of Biogen Pharmachem.
- Interface Financial Services' holding in Biogen Pharmachem is now 4.84%.
- The transaction was made under SEBI Takeover Regulations.
- Biogen Pharmachem's equity share capital remains unchanged at ₹90,26,03,000.